
Murat Osman Arcasoy
Professor of Medicine · Duke Department of Medicine
Credentials: ·
History
- Present
Duke Department of Medicine
1997–1998
1992–1993- 1991–1992
Research
A double-blind, placebo-controlled trial of ruxolitinib for myelofibrosis
New England Journal of Medicine · 2012 · 1,753 citations
Journal of Hematology & Oncology · 2017 · 361 citations
The non-haematopoietic biological effects of erythropoietin
Review · British Journal of Haematology · 2008 · Sole author · 282 citations

12 papers
- SV
11 papers
- MT
10 papers
- EW
9 papers

9 papers
- BF
8 papers

8 papers

7 papers
Grants
- 2004–2010
Erythropoietin Receptors in Breast Cancer
National Cancer Institute · R01
Contact PI · $1.4M · Duke University
- 2003–2006
Role of Erythropoietin Receptor Signaling in Heart
National Institute of Diabetes and Digestive and Kidney Diseases · R21
Contact PI · $308K · Duke University
- 1998–2005
Erythropoietin Receptor Regulation of Erythropoiesis
National Institute of Diabetes and Digestive and Kidney Diseases · K08
Contact PI · $600.8K · Duke University


